Tuesday, 02 December 2025
Dr Bipin Pandey from the 糖心原创 has been selected as one of the 2025 European Molecular Biology Organization (EMBO) Young Investigators, a distinction awarded to exceptional young group leaders in the life sciences across Europe and beyond.
The EMBO Young Investigator Programme supports researchers within the first four years of establishing their independent laboratories. The programme provides financial support, mentoring, and access to a vibrant international network of leading scientists.
Dr Pandey from the School of Biosciences is part of a new cohort of 28 young investigators, who will be active members of the EMBO Young Investigator Programme for the next four years. His research focuses on understanding how plant roots sense and adapt to physical stresses in the soil environment, with the goal of improving crop resilience and resource efficiency.
“I am deeply honoured to be selected as an EMBO Young Investigator,” said Dr Pandey.
This recognition not only supports our fundamental research but also strengthens our collaborations across Europe. It will help us translate our discoveries on root growth and soil adaptation into strategies for improving crop performance in challenging environments.
The award reflects Nottingham’s growing international reputation for excellence in plant and environmental sciences.
The new EMBO Young Investigators benefit from a variety of networking opportunities for them and their lab members. They become part of a vibrant network of more than 800 current and former EMBO Young Investigators, Installation Grantees and Global Investigators. Further benefits include training and mentoring opportunities, as well as access to core facilities at the European Molecular Biology Laboratory in Heidelberg, Germany. Young investigators also receive a financial award of 15,000 euros. They can apply for additional grants of up to 10,000 euros per year and gain support for networking activities, such as joint group meetings or travelling to conferences.
EMBO is delighted to welcome the new young investigators. Their outstanding achievements demonstrate the excellence and ambition that will drive progress in the life sciences. We are pleased to support these young group leaders as they take the next steps in their careers, and we look forward to their discoveries and contributions to our community.
Story credits
More information is available from Dr Bipin Pandey on Bipin.Pandey@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.